MYGEMA Trademark

Trademark Overview

On Friday, February 26, 2021, a trademark application was filed for MYGEMA with the United States Patent and Trademark Office. The USPTO has given the MYGEMA trademark a serial number of 79310050. The federal status of this trademark filing is REGISTERED as of Tuesday, August 23, 2022. This trademark is owned by Bluebird Bio (UK) Ltd.. The MYGEMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in gene therapy, namely, for treatment of sickle cell disease
mygema

General Information

Serial Number79310050
Word MarkMYGEMA
Filing DateFriday, February 26, 2021
Status700 - REGISTERED
Status DateTuesday, August 23, 2022
Registration Number6823016
Registration DateTuesday, August 23, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 7, 2022

Trademark Statements

Pseudo MarkMY GEM A
Goods and ServicesPharmaceutical preparations and substances for use in gene therapy, namely, for treatment of sickle cell disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenetix Biotherapeutics, Inc.
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressUS
Party Namebluebird bio, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressUS
Party NameBluebird Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressUS
Party NameBluebird Bio, Inc.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressUS
Party NameBluebird Bio (UK) Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Saturday, May 8, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, May 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 14, 2021APPLICATION FILING RECEIPT MAILED
Friday, August 13, 2021CHANGE OF OWNER RECEIVED FROM IB
Thursday, September 9, 2021ASSIGNED TO EXAMINER
Friday, September 10, 2021NON-FINAL ACTION WRITTEN
Saturday, September 11, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 28, 2021REFUSAL PROCESSED BY MPU
Tuesday, September 28, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, October 9, 2021NEW REPRESENTATIVE AT IB RECEIVED
Monday, October 25, 2021REFUSAL PROCESSED BY IB
Thursday, March 24, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 24, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 24, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 25, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, March 27, 2022ASSIGNED TO LIE
Friday, April 1, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, April 29, 2022ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, May 18, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 7, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 7, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 23, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, August 23, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, August 26, 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, November 23, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, December 1, 2022FINAL DISPOSITION PROCESSED
Thursday, December 1, 2022FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, December 28, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, December 23, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, September 13, 2024NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, March 18, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 18, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 18, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 14, 2025NEW REPRESENTATIVE AT IB RECEIVED
Thursday, December 18, 2025CHANGE OF NAME/ADDRESS REC'D FROM IB

Related Keywords

mygema treatment sickle cell disease namely therapy preparations substances gene pharmaceutical